Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2010
09/07/2010US7790189 Triple helical oligonucleotide comprising polysaccharide carrier and unmethylated CpG motif for use as DNA vaccine in treatment of infection and metabolic disorders
09/07/2010US7790168 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
09/07/2010US7790166 Anti-CD40 antibodies capable of blocking B-cell activation
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010US7790157 Methods of modulating CARK protein activity
09/07/2010US7790152 Monoclonal antibodies that preferntially bind to proteins having cytolysis and immunogenic activity
09/07/2010US7790145 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent
09/07/2010CA2414774C Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
09/07/2010CA2368814C Use of glucosylceramide synthesis inhibitors in therapy
09/07/2010CA2368676C Sphingomyelin containing preparation
09/05/2010CA2665771A1 Method and kit for effecting screening and immunogenic treatment using crt and/or erp57 translocation
09/02/2010WO2010099526A1 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
09/02/2010WO2010099522A1 Enhanced migraine treatments based on ghrelin mimetics
09/02/2010WO2010099217A1 Modulation of neurogenesis using d-cycloserine combinations
09/02/2010WO2010099139A2 Combination anti-cancer therapy
09/02/2010WO2010098503A1 Therapeutic agent for interstitial pneumonia
09/02/2010WO2010098429A1 Immunologic adjuvant composition and use thereof
09/02/2010WO2010098298A1 Pharmaceutical composition comprising combination of compound having nutrient digestion/absorption inhibitory activity and cyclohexanecarboxamide derivative
09/02/2010WO2010098286A1 Pharmaceutical preparation containing mineralcorticoid receptor antagonist
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010098166A1 Cell adhesion inhibitor and use thereof
09/02/2010WO2010097595A1 Compositions for use in cardioplegia comprising esmolol and adenosine
09/02/2010WO2010097334A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097332A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010028246A3 Novel compositions and adjuvants
09/02/2010WO2009139921A3 Microorganisms for preventing and treating neoplasms accompanying cellular therapy
09/02/2010WO2009112274A3 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
09/02/2010WO2009112273A3 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
09/02/2010US20100222438 Methods compositions and article of manufacture for modulating bone growth
09/02/2010US20100222305 Complexes of phosphate derivatives
09/02/2010US20100221766 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221348 Therapeutic uses of dunaliella powder
09/02/2010US20100221322 Abuse-Resistant Pharmaceutical Dosage Form
09/02/2010US20100221299 Therapeutic stem cell nutrient composition and uses thereof
09/02/2010US20100221293 Controlled release formulations of opioid and nonopioid analgesics
09/02/2010US20100221270 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
09/02/2010US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
09/02/2010US20100221147 Dialysate of peritoneal dialysis and its preparation method
09/02/2010CA2753604A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753597A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753261A1 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
09/02/2010CA2752813A1 Enhanced migraine treatments based on ghrelin mimetics
09/01/2010EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection
09/01/2010EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2223682A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers
09/01/2010EP2222289A1 Treatment of oral pharyngeal dysphagia
09/01/2010EP1998778B1 Use of (s)-roscovitine for the prevention and/or treatment of neurological disorders
09/01/2010EP1662908B9 Composition and method for facilitating bone healing
09/01/2010EP1339866B1 Human testis specific serine/threonine kinase
09/01/2010EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
09/01/2010EP1255543B1 Use of retinoid-type compounds as antibacterial agents against staphylococcus aureus
09/01/2010CN1947794B Medicine composition containing sulfonylurea compounds and phenoxy acid type compounds
09/01/2010CN101820915A Methods and compositions for treating cancers
09/01/2010CN101820914A Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
09/01/2010CN101820892A Treatment regime for proliferative disorders
09/01/2010CN101817872A Orally administered peptides synergize statin activity
09/01/2010CN101816795A Nanometer magnetic control throat anesthesia compound preparation and use thereof
09/01/2010CN101816794A Antitumor agents
09/01/2010CN101816793A Compounds, formulations, and methods for treating or preventing rosacea
09/01/2010CN101816792A Combinations comprising epothilones and pharmaceutical uses thereof
09/01/2010CN101816791A Cefmetazole-containing and beta-lactamase inhibitor-containing medicinal composition
09/01/2010CN101816787A An allergen dosage form
09/01/2010CN101816663A Medicinal composition and injecta for curing avian toxoplasmosis, and preparation method thereof
09/01/2010CN101816658A HIV inhibiting pyrimidines derivatives
09/01/2010CN101816638A Methods and formulations for modulating the human sexual response
09/01/2010CN101229372B Medicine compounds for treating hypertension
08/2010
08/31/2010US7786174 Administering a compound that inhibits islet amyloid polypeptide-associated amyloid deposition, e.g., 8-hydroxy-5-quinolinesulfonic acid, sodium cyclohexylsulfamate, or octahydroisoquinolinyl-N-propanesulfonic acid; antidiabetic agents
08/31/2010US7786170 synergistic; Tumor necrosis factor related apoptosis inducing ligand and LAQ824 (N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide) Dacinostat, which augments Apo-2L/TRAIL-induced DISC (death inducing signaling complex) and apoptosis of human acute leukemia cells
08/31/2010US7786166 Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agent
08/31/2010US7786123 Indolylmaleimide derivatives
08/31/2010US7786101 A composition with drospirenone for pregnancy and cardiovascular diseases in women
08/31/2010US7786094 Use of beta-glucans against biological warfare weapons and pathogens including anthrax
08/31/2010US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease
08/31/2010US7785885 Rescue of plant cell cultures and suspensions after cryopreservation-induced damage
08/31/2010US7785817 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics
08/31/2010US7785803 Antibody diagnostic kits and methods of use
08/31/2010US7785632 angiogenesis inhibitors; tetraiodothyroacetic acid conjugated to glycolide-lactide copolymer; binds cell surface receptor for thyroid hormone on integrin alpha at cell membrane level and does not activate signal transduction
08/31/2010US7785630 Mixture of active material in matrix of fatty alcohol or acid and solid hydrocarbon; microsphere
08/31/2010US7785627 Daily dosage form comprising: controlled release core of an antihyperglycemic drug and an excipient.seal coat applied to the controlled release core; and immediate release thiazolidinedione coating over the seal coat; metformin hydrochloride and pioglitazone hydrochloride FDA Orange book listed patent
08/31/2010US7785626 proton pump inhibitor and histamine H2 receptor antagonist; sustained release; for treatment of conditions associated with an excessive secretion of gastric acid; provides a suitable combination of a rapid onset and a long-lasting duration of the effect
08/31/2010US7785619 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
08/31/2010US7785612 A vaccine comprising a polyglutamic acid coupled with phenylalanine ethyl ester as an adjuvant; biodegradable nanoparticles
08/31/2010US7785583 administering imiquimod and carrier to a site to induce local inflammation at the site, then administering antigen-loaded antigen presenting cells, to eliciting an immune response; immunology
08/31/2010US7785571 Treatment of fungal infections
08/31/2010US7784616 Dispenser for progestin used for acute maintenance treatment of DUB
08/31/2010CA2480427C Novel potassium-dependent sodium-calcium exchanger
08/31/2010CA2447779C Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
08/31/2010CA2397723C Brain, spinal and nerve injury treatment
08/26/2010WO2010096751A1 Compositions and methods for treating a disease mediated by soluble oligomeric amyloid beta
08/26/2010WO2010095965A1 The use of sulindac and/or its metabolite as adjuvant treatment for colon cancer in humans
08/26/2010WO2010095753A1 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
08/26/2010WO2010095158A1 Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof
08/26/2010WO2010094609A1 Pharmaceutical composition containing inhibiting agents of protein methyltransferase i and use thereof to treat tumor diseases
08/26/2010WO2009135614A3 Use of a virus regimen for the treatment of diseases
08/26/2010US20100216976 Sodium-independent transporter carrying acidic amino acid and its gene
08/26/2010US20100216787 Thiazole derivative
08/26/2010US20100216755 Anti-tumor agent
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 1151